AMGN vs TECH
By Alex · Tickerpine
Amgen Inc. vs Bio-Techne Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | TECH |
|---|---|---|
| Price | $416.18 | $72.23 |
| Market cap | $225.15B | $11.25B |
| P/E ratio | 25.7 | 103.2 |
| ROE | 91.47% | 5.34% |
| Profit margin | 22.95% | 9.05% |
| Revenue growth | 9.50% | -1.50% |
| Dividend yield | 2.43% | 0.44% |
| Beta | 0.41 | 1.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs TECH in plain English
- AMGN is the bigger company — about 20.0× the market cap of TECH.
- AMGN is cheaper on earnings (P/E 25.7 vs 103.2).
- AMGN earns a higher return on equity (91% vs 5%).
- AMGN is growing revenue faster (10% vs -2%).
- AMGN has the higher dividend yield (2.43% vs 0.44%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
TECH return calculator
See what $1,000 in Bio-Techne Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.